Biotechnology: In Vitro & In Vivo Diagnostic Substances stocks
Biotechnology: In Vitro & In Vivo Diagnostic Substances: 11 US common stocks over $300M. Rank 41 of 142 by the median 1-day move (+0.80%) on 6 Nov 2026, up 80 places from the session before. Median 1-day +0.80%, 1-month --, 6-month --. Biotechnology: In Vitro & In Vivo Diagnostic Substances and the other stock industry groups are ranked on one page, each with its stocks and median returns.
+ Details
US common stocks over $300M (no ETFs, preferreds, notes, warrants or units), grouped by the industry the exchange screener lists. An industry with fewer than 3 goes to Other and its sector.
Medians of the group's stocks: 1-day is the screener's change for the session; 1-month and 6-month are a stock's close over its close 21 and 126 sessions back, from our end-of-day store (kept since 23 Oct 2026), for the stocks with both closes.
Rank: by today's median 1-day move until the store has a month of sessions; then by the median 1-month return.
Session: 6 Nov 2026.
Every stock in the group: type INDUSTRY BIOTECHNOLOGY-IN-VITRO-AND-IN-VIVO-DIAGNOSTIC-SUBSTANCES in the terminal.
Information only, not advice.
- IDXX IDEXX Laboratories Inc. 53.26B market cap, +0.80% on the session.
- ORKA Oruka Therapeutics Inc. 6.81B market cap, +7.12% on the session.
- LNTH Lantheus Holdings Inc. 6.58B market cap, −0.09% on the session.
- NEOG Neogen Corporation 2.57B market cap, +0.69% on the session.
- CLDX Celldex Therapeutics Inc. 2.35B market cap, +5.66% on the session.
- NTLA Intellia Therapeutics Inc. 1.59B market cap, +2.25% on the session.
- QDEL QuidelOrtho Corporation 734.2M market cap, −16.67% on the session.
- ACHV Achieve Life Sciences Inc. 691.5M market cap, +5.41% on the session.
- MYGN Myriad Genetics Inc. 566.2M market cap, −5.88% on the session.
- NNNN Anbio Biotechnology Class A 559.7M market cap, +8.36% on the session.
More: stock industry groups, ranked
- Fluid Controls stocks, ranked three places higher
- Auto Manufacturing stocks, ranked two places higher
- Mining & Quarrying of Nonmetallic Minerals (No Fuels) stocks, ranked one place higher
- Computer Software: Programming Data Processing stocks, ranked one place lower
- Finance: Consumer Services stocks, ranked two places lower
- Medicinal Chemicals and Botanical Products stocks, ranked three places lower